Complement factor H: Using atomic resolution structure to illuminate disease mechanisms

Advances in Experimental Medicine and Biology

Volumn 632, Issue , 2008, Pages 117-142

  Barlow, Paul N ^a   Hageman, Gregory S ^b   Lea, Susan M ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CARBOHYDRATE; COMPLEMENT FACTOR H; ECULIZUMAB; SUGAR; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BINDING SITE; CARBOXY TERMINAL SEQUENCE; DISEASE PREDISPOSITION; GENE MUTATION; GENETIC VARIABILITY; HEMOLYTIC UREMIC SYNDROME; HUMAN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN STRUCTURE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; X RAY CRYSTALLOGRAPHY; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; IMMUNOLOGY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MOLECULAR GENETICS; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; RETINA MACULA DEGENERATION; SMALL ANGLE SCATTERING; STATIC ELECTRICITY; ULTRACENTRIFUGATION; X RAY DIFFRACTION;

BINDING SITES; COMPLEMENT FACTOR H; CRYSTALLOGRAPHY, X-RAY; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MACULAR DEGENERATION; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SCATTERING, SMALL ANGLE; STATIC ELECTRICITY; ULTRACENTRIFUGATION; X-RAY DIFFRACTION;

EID: 58149336975     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78952-1_10     Document Type: Review

References (125)

1. Abrera-Abeleda, M.A., Nishimura, C., Smith, J.L., Sethi, S., McRae, J.L., Murphy, B.F., Silvestri, G., Skerka, C., Jozsi, M., Zipfel, P.F., et al. (2006). Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease). Journal of Medical Genetics 43, 582-589
2. Alsenz, J., Lambris, J.D., Schulz, T.F., and Dierich, M.P. (1984). Localization of the complement-component-C3b-binding site and the cofactor activity for factor I in the 38kDa tryptic fragment of factor H. The Biochemical Journal 224, 389-398
3. Alsenz, J., Schulz, T.F., Lambris, J.D., Sim, R.B., and Dierich, M.P. (1985). Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. The Biochemical Journal 232, 841- 850
4. Anderson, D.H., Ozaki, S., Nealon, M., Neitz, J., Mullins, R.F., Hageman, G.S., and Johnson, L.V. (2001). Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. American Journal of Ophthalmology 131, 767-781
5. Aronen, M., Leijala, M., and Meri, S. (1990). Value of C-reactive protein in reflecting the magnitude of complement activation in children undergoing open heart surgery. Intensive Care Medicine 16, 128-132
6. Aslam, M. and Perkins, S.J. (2001). Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. Journal of Molecular Biology 309, 1117-1138
7. Bao, L., Haas, M., Kraus, D.M., Hack, B.K., Rakstang, J.K., Holers, V.M., and Quigg, R.J. (2003). Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice. Journal of American Society of Nephrology 14, 670-679 134 P.N. Barlow et al.
8. Barlow, P.N., Baron, M., Norman, D.G., Day, A.J., Willis, A.C., Sim, R.B., and Campbell, I.D. (1991). Secondary structure of a complement control protein module by twodimensional 1H NMR. Biochemistry 30, 997-1004
9. Barlow, P.N., Norman, D.G., Steinkasserer, A., Horne, T.J., Pearce, J., Driscoll, P.C., Sim, R.B., and Campbell, I.D. (1992). Solution structure of the fifth repeat of factor H: a second example of the complement control protein module. Biochemistry 31, 3626- 3634
10. Barlow, P.N., Steinkasserer, A., Norman, D.G., Kieffer, B., Wiles, A.P., Sim, R.B., and Campbell, I.D. (1993). Solution structure of a pair of complement modules by nuclear magnetic resonance. Journal of Molecular Biology 232, 268-284
11. Blackmore, T.K., Sadlon, T.A., Ward, H.M., Lublin, D.M., and Gordon, D.L. (1996). Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. Journal of Immunology 157, 5422-5427
12. Blackmore, T.K., Hellwage, J., Sadlon, T.A., Higgs, N., Zipfel, P.F., Ward, H.M., and Gordon, D.L. (1998). Identification of the second heparin-binding domain in human complement factor H. Journal of Immunology 160, 3342-3348
13. Buddles, M.R., Donne, R.L., Richards, A., Goodship, J., and Goodship, T.H. (2000). Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. American Journal of Human Genetics 66, 1721-1722
14. Clark, S.J., Higman, V.A., Mulloy, B., Perkins, S.J., Lea, S.M., Sim, R.B., and Day, A.J. (2006). His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. The Journal of Biological Chemistry 281, 24713-24720
15. Coffey, P.J., Gias, C., McDermott, C.J., Lundh, P., Pickering, M.C., Sethi, C., Bird, A., Fitzke, F.W., Maass, A., Chen, L.L., et al. (2007). Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proceedings of the National Academy of Sciences of the United States of America 104, 16651-16656
16. Crabb, J.W., Miyagi, M., Gu, X., Shadrach, K., West, K.A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M.E., et al. (2002). Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 99, 14682-14687
17. de Cordoba, S.R. and de Jorge, E.G. (2008). Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. Clinical and Experimental Immunology 151, 1-13
18. Edwards, A.O., Ritter, R., III, Abel, K.J., Manning, A., Panhuysen, C., and Farrer, L.A. (2005). Complement factor H polymorphism and age-related macular degeneration. Science 308, 421-424
19. Esparza-Gordillo, J., Soria, J.M., Buil, A., Almasy, L., Blangero, J., Fontcuberta, J., and Rodriguez de Cordoba, S. (2004). Genetic and environmental factors influencing the human factor H plasma levels. Immunogenetics 56, 77-82
20. Estaller, C., Koistinen, V., Schwaeble, W., Dierich, M.P., and Weiss, E.H. (1991). Cloning of the 1.4-kb mRNA species of human complement factor H reveals a novel member of the short consensus repeat family related to the carboxy terminal of the classical 150- kDa molecule. Journal of Immunology 146, 3190-3196
21. Farries, T.C., Seya, T., Harrison, R.A., and Atkinson, J.P. (1990). Competition for binding sites on C3b by CR1, CR2, MCP, factor B and Factor H. Complement and Inflammation 7, 30-41
22. Fernando, A.N., Furtado, P.B., Clark, S.J., Gilbert, H.E., Day, A.J., Sim, R.B., and Perkins, S.J. (2007). Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin. Journal of Molecular Biology 368, 564-581
23. Ferreira, V.P., Herbert, A.P., Hocking, H.G., Barlow, P.N., and Pangburn, M.K. (2006). Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. Journal of Immunology 177, 6308-6316
24. Gehrs, K.M., Anderson, D.H., Johnson, L.V., and Hageman, G.S. (2006). Age-related macular degeneration - emerging pathogenetic and therapeutic concepts. Annals of Medicine 38, 450-471
25. Gerber, A., Kirchhoff-Moradpour, A.H., Obieglo, S., Brandis, M., Kirschfink, M., Zipfel, P.F., Goodship, J.A., and Zimmerhackl, L.B. (2003). Successful (?) therapy of hemolytic-uremic syndrome with factor H abnormality. Pediatric Nephrology (Berlin, Germany) 18, 952-955
26. Gershov, D., Kim, S., Brot, N., and Elkon, K.B. (2000). C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. The Journal of Experimental Medicine 192, 1353-1364
27. Giannakis, E., Jokiranta, T.S., Male, D.A., Ranganathan, S., Ormsby, R.J., Fischetti, V.A., Mold, C., and Gordon, D.L. (2003). A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. European Journal of Immunology 33, 962-969
28. Gold, B., Merriam, J.E., Zernant, J., Hancox, L.S., Taiber, A.J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., Barile, G.R., et al. (2006). Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nature Genetics 38, 458-462
29. Gordon, D.L., Kaufman, R.M., Blackmore, T.K., Kwong, J., and Lublin, D.M. (1995). Identification of complement regulatory domains in human factor H. Journal of Immunology 155, 348-356
30. Hageman, G.S., Mullins, R.F., Russell, S.R., Johnson, L.V., and Anderson, D.H. (1999). Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells. FASEB J 13, 477-484
31. Hageman, G.S., Luthert, P.J., Victor Chong, N.H., Johnson, L.V., Anderson, D.H., and Mullins, R.F. (2001). An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and agerelated macular degeneration. Progress in Retinal and Eye Research 20, 705-732
32. Hageman, G.S., Anderson, D.H., Johnson, L.V., Hancox, L.S., Taiber, A.J., Hardisty, L.I., Hageman, J.L., Stockman, H.A., Borchardt, J.D., Gehrs, K.M., et al. (2005). A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America 102, 7227-7232
33. Hageman, G.S., Hancox, L.S., Taiber, A.J., Gehrs, K.M., Anderson, D.H., Johnson, L.V., Radeke, M.J., Kavanagh, D., Richards, A., Atkinson, J., et al. (2006). Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Annals of Medicine 38, 592-604
34. Haines, J.L., Hauser, M.A., Schmidt, S., Scott, W.K., Olson, L.M., Gallins, P., Spencer, K.L., Kwan, S.Y., Noureddine, M., Gilbert, J.R., et al. (2005). Complement factor H variant increases the risk of age-related macular degeneration. Science (New York, NY) 308, 419-421
35. Hakobyan, S., Harris, C.L., van den Berg, C., Pepys, M.B., Morgan, B.P. (2007). Binding of factor H to C-reactive protein occurs only when the latter has undergone nonphysiologic denaturation. Molecular Immunology 44, 3983-3984
36. Hamilton, G., Proitsi, P., Williams, J., O'Donovan, M., Owen, M., Powell, J., and Lovestone, S. (2007). Complement factor H Y402H polymorphism is not associated with late-onset Alzheimer's disease. Neuromolecular Medicine 9, 331-334
37. Hegasy, G.A., Manuelian, T., Hogasen, K., Jansen, J.H., and Zipfel, P.F. (2002). The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion. The American Journal of Pathology 161, 2027-2034
38. Heinen, S., Sanchez-Corral, P., Jackson, M.S., Strain, L., Goodship, J.A., Kemp, E.J., Skerka, C., Jokiranta, T.S., Meyers, K., Wagner, E., et al. (2006). De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Human Mutation 27, 292-293
39. Herbert, A.P., Uhrin, D., Lyon, M., Pangburn, M.K., and Barlow, P.N. (2006). Diseaseassociated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure. The Journal of Biological Chemistry 281, 16512-16520
40. Herbert, A.P., Deakin, J.A., Schmidt, C.Q., Blaum, B.S., Egan, C., Ferreira, V.P., Pangburn, M.K., Lyon, M., Uhrin, D., and Barlow, P.N. (2007). Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. The Journal of Biological Chemistry 282, 18960-18968
41. Holers, V.M. (2003). The complement system as a therapeutic target in autoimmunity. Clinical Immunology (Orlando, Fla) 107, 140-151
42. Holers, V.M., Girardi, G., Mo, L., Guthridge, J.M., Molina, H., Pierangeli, S.S., Espinola, R., Xiaowei, L.E., Mao, D., Vialpando, C.G., et al. (2002). Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. The Journal of Experimental Medicine 195, 211-220
43. Hughes, A.E., Orr, N., Esfandiary, H., Diaz-Torres, M., Goodship, T., and Chakravarthy, U. (2006). A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nature Genetics 38, 1173-1177
44. Jakobsdottir, J., Conley, Y.P., Weeks, D.E., Mah, T.S., Ferrell, R.E., and Gorin, M.B. (2005). Susceptibility genes for age-related maculopathy on chromosome 10q26. American Journal of Human Genetics 77, 389-407
45. Jansen, J.H., Hogasen, K., Harboe, M., and Hovig, T. (1998). In situ complement activation in porcine membranoproliferative glomerulonephritis type II. Kidney International 53, 331-349
46. Jarva, H., Jokiranta, T.S., Hellwage, J., Zipfel, P.F., and Meri, S. (1999). Regulation ofcomplement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. Journal of Immunology 163, 3957-3962
47. Johnson, L.V., Ozaki, S., Staples, M.K., Erickson, P.A., and Anderson, D.H. (2000). A potential role for immune complex pathogenesis in drusen formation. Experimental Eye Research 70, 441-449
48. Johnson, L.V., Leitner, W.P., Staples, M.K., and Anderson, D.H. (2001). Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Experimental Eye Research 73, 887-896
49. Johnson, P.T., Betts, K.E., Radeke, M.J., Hageman, G.S., Anderson, D.H., and Johnson, L.V. (2006). Individuals homozygous for the age-related macular degeneration risk conferring variant of complement factor H have elevated levels of CRP in the choroid. Proceedings of the National Academy of Sciences of the United States of America 103, 17456-17461
50. Jokiranta, T.S., Hellwage, J., Koistinen, V., Zipfel, P.F., and Meri, S. (2000). Each of the three binding sites on complement factor H interacts with a distinct site on C3b. The Journal of Biological Chemistry 275, 27657-27662
51. Jokiranta, T.S., Jaakola, V.P., Lehtinen, M.J., Parepalo, M., Meri, S., and Goldman, A. (2006). Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome. The EMBO Journal 25, 1784-1794
52. Jouvin, M.H., Kazatchkine, M.D., Cahour, A., and Bernard, N. (1984). Lysine residues, but not carbohydrates, are required for the regulatory function of H on the amplification C3 convertase of complement. Journal of Immunology 133, 3250-3254
53. Kardys, I., Klaver, C.C., Despriet, D.D., Bergen, A.A., Uitterlinden, A.G., Hofman, A., Oostra, B.A., Van Duijn, C.M., de Jong, P.T., and Witteman, J.C. (2006). A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. Journal of the American College of Cardiology 47, 1568-1575
54. Kavanagh, D., Richards, A., Fremeaux-Bacchi, V., Noris, M., Goodship, T., Remuzzi, G., and Atkinson, J.P. (2007). Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome. Clinical Journal of American Society of Nephrology 2, 591-596
55. Kinoshita, T. (1991). Biology of complement: the overture. Immunology today 12, 291-295 Klein, R.J., Zeiss, C., Chew, E.Y., Tsai, J.Y., Sackler, R.S., Haynes, C., Henning, A.K., SanGiovanni, J.P., Mane, S.M., Mayne, S.T., et al. (2005). Complement factor H polymorphism in age-related macular degeneration. Science 308, 385-389
56. Kuhn, S. and Zipfel, P.F. (1996). Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H. European Journal of Immunology 26, 2383-2387
57. Kuhn, S., Skerka, C., and Zipfel, P.F. (1995). Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. Journal of Immunology 155, 5663-5670
58. Laine, M., Jarva, H., Seitsonen, S., Haapasalo, K., Lehtinen, M.J., Lindeman, N., Anderson, D.H., Johnson, P.T., Jarvela, I., Jokiranta, T.S., et al. (2007). Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. Journal of Immunology 178, 3831-3836
59. Li, M., Atmaca-Sonmez, P., Othman, M., Branham, K.E., Khanna, R., Wade, M.S., Li, Y., Liang, L., Zareparsi, S., Swaroop, A., et al. (2006). CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nature Genetics 38, 1049-1054
60. Licht, C., Weyersberg, A., Heinen, S., Stapenhorst, L., Devenge, J., Beck, B., Waldherr, R., Kirschfink, M., Zipfel, P.F., and Hoppe, B. (2005). Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15. American Journal of Kidney Disease 45, 415-421
61. Licht, C., Heinen, S., Jozsi, M., Loschmann, I., Saunders, R.E., Perkins, S.J., Waldherr, R., Skerka, C., Kirschfink, M., Hoppe, B., et al. (2006). Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). Kidney International 70, 42-50
62. Lindahl, G., Sjobring, U., and Johnsson, E. (2000). Human complement regulators: a major target for pathogenic microorganisms. Current Opinion in Immunology 12, 44-51
63. Liszewski, M.K., and Atkinson, J.P. (1998). Novel complement inhibitors. Expert Opinion on Investigational Drugs 7, 323-331
64. Male, D.A., Ormsby, R.J., Ranganathan, S., Giannakis, E., and Gordon, D.L. (2000). Complement factor H: sequence analysis of 221 kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes. Molecular Immunology 37, 41-52
65. Maller, J.B., Fagerness, J.A., Reynolds, R.C., Neale, B.M., Daly, M.J., and Seddon, J.M. (2007). Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nature Genetics 39, 1200-1201
66. Markiewski, M.M. and Lambris, J.D. (2007). The role of complement in inflammatory diseases from behind the scenes into the spotlight. The American Journal of Pathology 171, 715-727
67. Meng, W., Hughes, A., Patterson, C.C., Belton, C., Kamaruddin, M.S., Horan, P.G., Kee, F., and McKeown, P.P. (2007). Genetic variants of complement factor H gene are not associated with premature coronary heart disease: a family-based study in the Irish population. BMC Medical Genetics 8, 62
68. Meri, S. and Pangburn, M.K. (1990). Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proceedings of the National Academy of Sciences of the United States of America 87, 3982-3986
69. Misasi, R., Huemer, H.P., Schwaeble, W., Solder, E., Larcher, C., and Dierich, M.P. (1989). Human complement factor H: an additional gene product of 43 kDa isolated from human plasma shows cofactor activity for the cleavage of the third component of complement. European Journal of Immunology 19, 1765-1768
70. Mooijaart, S.P., Koeijvoets, K.M., Sijbrands, E.J., Daha, M.R., and Westendorp, R.G. (2007). Complement Factor H polymorphism Y402H associates with inflammation, visual acuity, and cardiovascular mortality in the elderly population at large. Experimental Gerontology 42, 1116-1122
71. Mullins, R.F., Russell, S.R., Anderson, D.H., and Hageman, G.S. (2000). Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14, 835-846
72. Mullins, R.F., Aptsiauri, N., and Hageman, G.S. (2001). Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye (London, England) 15, 390-395
73. Nan, R., Gor, J., and Perkins, S.J. (2008). Implications of the progressive self-association of wild-type human factor H for complement regulation and disease. Journal of Molecular Biology 375, 891-900
74. Nicaud, V., Francomme, C., Ruidavets, J.B., Luc, G., Arveiler, D., Kee, F., Evans, A., Morrison, C., Blankenberg, S., Cambien, F., et al. (2007). Lack of association between complement factor H polymorphisms and coronary artery disease or myocardial infarction. Journal of Molecular Medicine 85, 771-775
75. Norman, D.G., Barlow, P.N., Baron, M., Day, A.J., Sim, R.B., and Campbell, I.D. (1991). Three-dimensional structure of a complement control protein module in solution. Journal of Molecular Biology 219, 717-725
76. Okamoto, H., Umeda, S., Obazawa, M., Minami, M., Noda, T., Mizota, A., Honda, M., Tanaka, M., Koyama, R., Takagi, I., et al. (2006). Complement factor H polymorphisms in Japanese population with age-related macular degeneration. Molecular Vision 12, 156-158
77. Okemefuna, A.I., Gilbert, H.E., Griggs, K.M., Ormsby, R.J., Gordon, D.L., and Perkins, S.J. (2008). The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties. Journal of Molecular Biology 375, 80-101
78. Oppermann, M., Manuelian, T., Jozsi, M., Brandt, E., Jokiranta, T.S., Heinen, S., Meri, S., Skerka, C., Gotze, O., and Zipfel, P.F. (2006). The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein. Clinical and Experimental Immunology 144, 342-352
79. Ormsby, R.J., Jokiranta, T.S., Duthy, T.G., Griggs, K.M., Sadlon, T.A., Giannakis, E., and Gordon, D.L. (2006). Localization of the third heparin-binding site in the human complement regulator factor H1. Molecular Immunology 43, 1624-1632
80. Pai, J.K., Manson, J.E., Rexrode, K.M., Albert, C.M., Hunter, D.J., and Rimm, E.B. (2007). Complement factor H (Y402H) polymorphism and risk of coronary heart disease in US men and women. European Heart Journal 28, 1297-1303
81. Pangburn, M.K., and Muller-Eberhard, H.J. (1983). Kinetic and thermodynamic analysis of the control of C3b by the complement regulatory proteins factors H and I. Biochemistry 22, 178-185
82. Pangburn, M.K., Schreiber, R.D., and Muller-Eberhard, H.J. (1977). Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. The Journal of Experimental Medicine 146, 257-270
83. Pangburn, M.K., Atkinson, M.A., and Meri, S. (1991). Localization of the heparin-binding site on complement factor H. The Journal of Biological Chemistry 266, 16847-16853
84. Penfold, P.L., Madigan, M.C., Gillies, M.C., and Provis, J.M. (2001). Immunological and aetiological aspects of macular degeneration. Progress in Retinal and Eye Research 20, 385-414
85. Perkins, S.J., Nealis, A.S., and Sim, R.B. (1991). Oligomeric domain structure of human complement factor H by X-ray and neutron solution scattering. Biochemistry 30, 2847- 2857
86. Perkins, S.J., Gilbert, H.E., Aslam, M., Hannan, J., Holers, V.M., and Goodship, T.H. (2002). Solution structures of complement components by X-ray and neutron scattering and analytical ultracentrifugation. Biochemical Society Transactions 30, 996-1001
87. Pickering, M.C. and Cook, H.T. (2008). Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. Clinical and Experimental Immunology 151, 210-230
88. Pickering, M.C., Cook, H.T., Warren, J., Bygrave, A.E., Moss, J., Walport, M.J., and Botto, M. (2002). Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nature Genetics 31, 424- 428
89. Pickering, M.C., de Jorge, E.G., Martinez-Barricarte, R., Recalde, S., Garcia-Layana, A., Rose, K.L., Moss, J., Walport, M.J., Cook, H.T., de Cordoba, S.R., et al. (2007). Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. The Journal of Experimental Medicine 204, 1249-1256
90. Prosser, B.E., Johnson, S., Roversi, P., Clark, S.J., Tarelli, E., Sim, R.B., Day, A.J., and Lea, S.M. (2007a). Expression, purification, cocrystallization and preliminary crystallographic analysis of sucrose octasulfate/human complement regulator factor H SCRs 6-8. Acta Crystallographica 63, 480-483
91. Prosser, B.E., Johnson, S., Roversi, P., Herbert, A.P., Blaum, B.S., Tyrrell, J., Jowitt, T.A., Clark, S.J., Tarelli, E., Uhrin, D., et al. (2007b). Structural basis for complement factor H linked age-related macular degeneration. The Journal of Experimental Medicine 204, 2277-2283
92. Pulido, J.S., McConnell, J.P., Lennon, R.J., Bryant, S.C., Peterson, L.M., Berger, P.B., Somers, V., and Highsmith, W.E. (2007). Relationship between age-related macular degeneration-associated variants of complement factor H and LOC387715 with coronary artery disease. Mayo Clinic Proceedings 82, 301-307
93. Richards, A., Buddles, M.R., Donne, R.L., Kaplan, B.S., Kirk, E., Venning, M.C., Tielemans, C.L., Goodship, J.A., and Goodship, T.H. (2001). Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. American Journal of Human Genetics 68, 485-490
94. Ricklin, D. and Lambris, J.D. (2007). Complement-targeted therapeutics. Nature Biotechnology 25, 1265-1275
95. Ripoche, J., Day, A.J., Willis, A.C., Belt, K.T., Campbell, R.D., and Sim, R.B. (1986). Partial characterization of human complement factor H by protein and cDNA sequencing: homology with other complement and non-complement proteins. Bioscience Reports 6, 65-72
96. Ripoche, J., Erdei, A., Gilbert, D., Al Salihi, A., Sim, R.B., and Fontaine, M. (1988). Two populations of complement factor H differ in their ability to bind to cell surfaces. The Biochemical Journal 253, 475-480
97. Rivera, A., Fisher, S.A., Fritsche, L.G., Keilhauer, C.N., Lichtner, P., Meitinger, T., and Weber, B.H. (2005). Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Human Molecular Genetics 14, 3227-3236
98. Rodriguez de Cordoba, S., Lublin, D.M., Rubinstein, P., and Atkinson, J.P. (1985). Human genes for three complement components that regulate the activation of C3 are tightly linked. The Journal of Experimental Medicine 161, 1189-1195
99. Rother, R.P., Rollins, S.A., Mojcik, C.F., Brodsky, R.A., and Bell, L. (2007). Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nature Biotechnology 25, 1256-1264
100. Ryan, U.S. (1995). Complement inhibitory therapeutics and xenotransplantation. Nature Medicine 1, 967-968
101. Sahu, A., and Lambris, J.D. (2000). Complement inhibitors: a resurgent concept in antiinflammatory therapeutics. Immunopharmacology 49, 133-148
102. Schlaf, G., Demberg, T., Beisel, N., Schieferdecker, H.L., and Gotze, O. (2001). Expression and regulation of complement factors H and I in rat and human cells: some critical notes. Molecular Immunology 38, 231-239
103. Schmidt, C.Q., Herbert, A.P., Hocking, H.G., Uhrin, D., and Barlow, P.N. (2008). Translational mini-review series on complement factor H: structural and functional correlations for factor H. Clinical and Experimental Immunology 151, 14-24
104. Schwaeble, W., Zwirner, J., Schulz, T.F., Linke, R.P., Dierich, M.P., and Weiss, E.H. (1987). Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver. European Journal of Immunology 17, 1485-1489
105. Seddon, J.M., George, S., Rosner, B., and Klein, M.L. (2006). CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Human Heredity 61, 157-165
106. Sharma, A.K. and Pangburn, M.K. (1996). Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proceedings of the National Academy of Sciences of the United States of America 93, 10996-11001
107. Sivaprasad, S., Chong, N.V., and Bailey, T.A. (2005). Serum elastin-derived peptides in agerelated macular degeneration. Investigative Ophthalmology and Visual Science 46, 3046-3051
108. Sjoberg, A.P., Trouw, L.A., Clark, S.J., Sjolander, J., Heinegard, D., Sim, R.B., Day, A.J., and Blom, A.M. (2007). The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to Creactive protein, fibromodulin, DNA, and necrotic cells. The Journal of Biological Chemistry 282, 10894-10900
109. Skerka, C., Lauer, N., Weinberger, A.A., Keilhauer, C.N., Suhnel, J., Smith, R., Schlotzer- Schrehardt, U., Fritsche, L., Heinen, S., Hartmann, A., et al. (2007). Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. Molecular Immunology 44, 3398-3406
110. Soares, D.C., Gerloff, D.L., Syme, N.R., Coulson, A.F., Parkinson, J., and Barlow, P.N. (2005). Large-scale modelling as a route to multiple surface comparisons of the CCP module family. Protein Engineering Design and Selection 18, 379-388
111. Stark, K., Neureuther, K., Sedlacek, K., Hengstenberg, W., Fischer, M., Baessler, A., Wiedmann, S., Jeron, A., Holmer, S., Erdmann, J., et al. (2007). The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors. Clinical Science (Lond) 113, 213-218
112. Stratton, J.D., and Warwicker, P. (2002). Successful treatment of factor H-related haemolytic uraemic syndrome. Nephrology Dialysis Transplantation 17, 684-685
113. Thurman, J.M. (2007). Triggers of inflammation after renal ischemia/reperfusion. Clinical Immunology (Orlando, Fla) 123, 7-13
114. Thurman, J.M., and Holers, V.M. (2006). The central role of the alternative complement pathway in human disease. Journal of Immunology 176, 1305-1310
115. Topol, E.J., Smith, J., Plow, E.F., and Wang, Q.K. (2006). Genetic susceptibility to myocardial infarction and coronary artery disease. Human Molecular Genetics 15 Spec No 2, R117-R123
116. Turnbull, J., Powell, A., and Guimond, S. (2001). Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends in Cell Bbiology 11, 75-82
117. Verdugo, M.E. and Ray, J. (1997). Age-related increase in activity of specific lysosomal enzymes in the human retinal pigment epithelium. Experimental Eye Research 65, 231- 240
118. Warwicker, P., Goodship, T.H., Donne, R.L., Pirson, Y., Nicholls, A., Ward, R.M., Turnpenny, P., and Goodship, J.A. (1998). Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney International 53, 836-844
119. Weeks, D.E., Conley, Y.P., Tsai, H.J., Mah, T.S., Schmidt, S., Postel, E.A., Agarwal, A., Haines, J.L., Pericak-Vance, M.A., Rosenfeld, P.J., et al. (2004). Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. American Journal of Human Genetics 75, 174- 189
120. Yates, J.R., Sepp, T., Matharu, B.K., Khan, J.C., Thurlby, D.A., Shahid, H., Clayton, D.G., Hayward, C., Morgan, J., Wright, A.F., et al. (2007). Complement C3 variant and the risk of age-related macular degeneration. The New England Journal of Medicine 357, 553-561
121. Yu, J., Wiita, P., Kawaguchi, R., Honda, J., Jorgensen, A., Zhang, K., Fischetti, V.A., and Sun, H. (2007). Biochemical analysis of a common human polymorphism associated with age-related macular degeneration. Biochemistry 46, 8451-8461
122. Zarbin, M.A. (2004). Current concepts in the pathogenesis of age-related macular degeneration. Archives of Ophthalmology 122, 598-614
123. Zetterberg, M., Tasa, G., Palmer, M.S., Juronen, E., Teesalu, P., Blennow, K., and Zetterberg, H. (2007). Apolipoprotein E polymorphisms in patients with primary openangle glaucoma. American Journal of Ophthalmology 143, 1059-1060
124. Zipfel, P.F. and Skerka, C. (1994). Complement factor H and related proteins: an expanding family of complement-regulatory proteins? Immunology Today 15, 121-126
125. Zipfel, P.F., Jokiranta, T.S., Hellwage, J., Koistinen, V., and Meri, S. (1999). The factor H protein family. Immunopharmacology 42, 53-60